Figure 3.

The association between beta-blocker therapy and health-related quality of life (HRQOL). A) The adjusted association between beta-blocker therapy at baseline and HRQOL; B) The adjusted association between beta-blocker therapy at follow-up and HRQOL. Adjusted for age, gender, diabetes mellitus, hypertension, hypercholesterolemia, renal dysfunction, current smoking, obesity, type of surgery, previous ischemic heart disease, heart failure, cerebrovascular event or transient ischemic attack, statins, aspirin, corticosteroids, bronchodilators, year of surgery, number of follow-up years (for Figure 2a) and propensity score.

Abbreviations: PF, physical functioning; RP, role physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; Re, role emotional; MH, mental health; OR, odds ratio; CI, confidence interval.